Demographic and clinical information of HIV-1–seropositive individuals
Patients . | Age, y . | Sex . | Time HIV positive, y . | CD4+ cells/μL . | HIV viral load, copies/mL . | HLA*0201 . |
---|---|---|---|---|---|---|
P1 | 55 | M | 5 | 558 | < 50 | – |
P2 | 36 | M | 2 | 537 | < 400 | + |
P3 | 41 | M | 1 | 572 | 4 180 | – |
P4 | 36 | M | 1 | 571 | 52 900 | + |
P5 | 37 | M | 3 | 803 | 9 740 | + |
P6 | 49 | M | 9 | 669 | 37 800 | – |
P7 | 44 | M | 3 | 414 | 159 000 | – |
P8 | 40 | M | 4 | 539 | 4 710 | + |
P9 | 43 | M | 3 | 755 | 2 790 | + |
P10 | 56 | F | 3 | 621 | < 400 | – |
P11 | 45 | M | 1 | 871 | 25 400 | + |
P12 | 30 | M | 4 | 495 | 30 500 | + |
P13 | 33 | M | 1 | 900 | < 500 | – |
P14 | 40 | M | 1 | 543 | 18 000 | – |
P15 | 23 | F | 3 | 874 | 1 300 | + |
P16 | 55 | F | 2 | 532 | 25 100 | – |
P17 | 36 | M | 1 | 497 | 19 700 | – |
P18 | 35 | M | 8 | 546 | < 50 | + |
P19 | 46 | M | 1 | 1552 | 26 500 | – |
P20 | 40 | M | 0.5 | 679 | 461 000 | + |
P21 | 51 | M | 0.5 | 542 | 140 000 | – |
P22 | 39 | M | 2 | 763 | 30 000 | – |
P23 | 29 | M | 0.25 | 470 | 215 000 | – |
P24 | 28 | M | 1 | 610 | 28 800 | – |
P25 | 27 | M | 2 | 486 | 57 600 | + |
P26 | 42 | M | 3 | 390 | 43 500 | – |
P27 | 30 | M | 1 | 575 | 24 400 | + |
P28 | 31 | M | 2 | 547 | 77 000 | + |
Patients . | Age, y . | Sex . | Time HIV positive, y . | CD4+ cells/μL . | HIV viral load, copies/mL . | HLA*0201 . |
---|---|---|---|---|---|---|
P1 | 55 | M | 5 | 558 | < 50 | – |
P2 | 36 | M | 2 | 537 | < 400 | + |
P3 | 41 | M | 1 | 572 | 4 180 | – |
P4 | 36 | M | 1 | 571 | 52 900 | + |
P5 | 37 | M | 3 | 803 | 9 740 | + |
P6 | 49 | M | 9 | 669 | 37 800 | – |
P7 | 44 | M | 3 | 414 | 159 000 | – |
P8 | 40 | M | 4 | 539 | 4 710 | + |
P9 | 43 | M | 3 | 755 | 2 790 | + |
P10 | 56 | F | 3 | 621 | < 400 | – |
P11 | 45 | M | 1 | 871 | 25 400 | + |
P12 | 30 | M | 4 | 495 | 30 500 | + |
P13 | 33 | M | 1 | 900 | < 500 | – |
P14 | 40 | M | 1 | 543 | 18 000 | – |
P15 | 23 | F | 3 | 874 | 1 300 | + |
P16 | 55 | F | 2 | 532 | 25 100 | – |
P17 | 36 | M | 1 | 497 | 19 700 | – |
P18 | 35 | M | 8 | 546 | < 50 | + |
P19 | 46 | M | 1 | 1552 | 26 500 | – |
P20 | 40 | M | 0.5 | 679 | 461 000 | + |
P21 | 51 | M | 0.5 | 542 | 140 000 | – |
P22 | 39 | M | 2 | 763 | 30 000 | – |
P23 | 29 | M | 0.25 | 470 | 215 000 | – |
P24 | 28 | M | 1 | 610 | 28 800 | – |
P25 | 27 | M | 2 | 486 | 57 600 | + |
P26 | 42 | M | 3 | 390 | 43 500 | – |
P27 | 30 | M | 1 | 575 | 24 400 | + |
P28 | 31 | M | 2 | 547 | 77 000 | + |